Roundtable Discussion: Physiology-guided PCI: What is the Right Choice for the Most Accurate Decision Making?
Published: 21 September 2018
-
Views:
94
-
Likes:
7
-
Views:
94
-
Likes:
7
-
Up Next
-
Part 1 INTRODUCTION: PHYSIOLOGY Adrian P Banning, Thomas Engstrøm, Giuseppe Tarantini
-
Part 2 SESSION 1: LITERATURE REVIEW Adrian P Banning
-
Part 3 SESSION 2: EXPERIENCES & LIMITATIONS OF FFR & iFR Adrian P Banning, Thomas Engstrøm, Giuseppe Tarantini
Overview
This expert-led discussion was filmed on 21st September 2018 with Professor Adrian Banning (as moderator) and Professors Thomas Engstrøm and Giuseppe Tarantini. This footage aims to highlight the limitations of FFR and iFR and how novel technologies and emerging resting indicies may offer solutions in coronary physiology.
Learning objective
- learn more about patient-specific decision making strategies in physiology-guided PCI.
- discuss the limitations of FFR and iFR measurements and gain insight on how to overcome them.
- become aware of signal drift on pressure guidewire and novel technologies that limit its impact on accuracy.
- assess the role of emerging resting indices such as dPR.
- listen to the personal insight of Cardiology Key Opinion Leaders on the future of coronary physiology.
Target Audience
- Interventional Cardiologist doing more than 50 physiology-guided PCI per year
- Believers in iFR and/or FFR
More from this programme
Part 1
INTRODUCTION: PHYSIOLOGY
| 1 session | |
| INTRODUCTION: PHYSIOLOGY | Watch now |
Part 2
SESSION 1: LITERATURE REVIEW
| 1 session | |
| SESSION 1: LITERATURE REVIEW | Watch now |
Part 3
SESSION 2: EXPERIENCES & LIMITATIONS OF FFR & iFR
Part 4
SESSION 3: TECHNOLOGY FOCUS
| 1 session | |
| SESSION 3: TECHNOLOGY FOCUS | Watch now |
Faculty Biographies
Adrian P Banning
Dr Adrian Banning is a consultant cardiologist specialising in percutaneous coronary intervention.
He is the president of the British Cardiac Intervention Society and was previously the Divisional Director for Cardiology, Cardiothoracic and Vascular Surgery at the John Radcliffe University Hospital, Oxford. Through his position at the John Radcliffe, and his own practice at Oxford’s The Manor Hospital, Prof Banning provides specialist regional services for coronary and valvular heart disease patients to an area of 1.2 million people.
Prof Banning is pioneering research in his field and lectures nationally and internationally. He has authored several books on coronary intervention and has more than 300 PubMed listed scientific papers to his name.
Thomas Engstrøm
Dr Thomas Engstrøm MD is currently head of interventional cardiology at Rigshospital in Copenhagen. Engstrøm studied at the University of Copenhagen and trained at Gentofte University Hospital, Skejby University Hospital and Rigshospitalet in Denmark. He is the author of more than 120 scientific articles in peer-reviewed journals.
Giuseppe Tarantini
Prof Giuseppe Tarantini serves as Head of the Interventional Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua Medical School, Padua (Italy) and in an internationally renowned researcher in the fields of ischemic heart disease, structural heart disease and cardiomyopathies.
He acts as first operator for a wide range of interventional procedures including Coronary interventions (including atherectomies), Peripheral interventions (Carotid and Renal) and Structural Heart interventions (ASDs, PFOs, TAVI and AVP).
Prof Tarantini is a faculty member of a number of international conferences including Transcatheter Cardiovascular Therapeutics (TCT), Congresso della Societa Italiana di Cardiologia Invasiva (SICI-GISE), Euro PCR and European Society of Cardiology (ESC). He has published 245 clinical papers and serves as an editorial board member and reviewer for a number of respected journals.